Help us: Donate
Follow us on:

Tag: Insilico Medicine

Insilico Medicine
Insilico Medicine, which uses AI for drug discovery, has identified potential dual-purpose therapeutic targets that are implicated in aging and age-associated diseases using artificial intelligence and a Hallmarks of Aging framework. The full press release is included here. March 29, 2022, New York (11AM ET) --- Insilico Medicine, a clinical stage end-to-end artificial intelligence (AI)-driven...
Taisho Pharmaceutical logo
Insilico Medicine has announced a historic deal with the Taisho Pharmaceutical Company, which is based in Japan, in a partnership to identify and develop new senolytic drugs. The companies have agreed to collaborate on AI-powered drug discovery focused on identifying molecules to remove problematic senescent cells. Why we Age: Cellular SenescenceAs your body ages, more...
AI drug discovery
Insilico Medicine has achieved a world first by successfully designing, synthesizing, and validating a new drug from the ground up and taking just 46 days to do so. It achieved this impressive feat using AI. This is the first time that AI has been used to successfully create a new drug, and it took record...

Want the latest longevity news? Subscribe to our Newsletter!